Gabriel Gomis

7PUBLICATIONS
57CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Instruments and techniquesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 07, 2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

|Aug 06, 2026
Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

|Jan 16, 2026
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Miguel F Sanmamed, Carlos E de Andrea, David Ruiz-Guillamon

|Apr 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Alvaro Teijeira, Saray Garasa, Maria C Ochoa

|Oct 02, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.

Ignacio Melero, Maria C Ochoa, Carmen Molina

|Aug 18, 2023
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Javier Glez-Vaz, Arantza Azpilikueta, María C Ochoa

Pageof 2

Frequent Collaborators

7 joint publications

Ignacio Melero

6 joint publications

Carlos Luri-Rey

5 joint publications

Alvaro Teijeira

5 joint publications

Pedro Berraondo